EUVIMEDEUVIMED entdecken
Crossref

Baseline interferon signaling in monocytes and antibody-mediated innate activation are associated with reactogenicity to mRNA vaccines

Natacha Madelon iD, Gustavo A Ruiz Buendía iD, Paula Torres Rodriguez iD, Yves R Donati, Paola Fontannaz, Matias Ciancaglini iD, Wafae Adouan, Emma Arsac iD, Nicolas Fonta iD, Rachel Goldstein iD, Nelli Heikkila iD, Nicolas Page und 9 weitere

Science Translational Medicine · 2026

DOI: 10.1126/scitranslmed.aee4776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Natacha Madelon und 20 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Monocytes, Interferons, Signal Transduction, Immunity, Innate. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Moderna, Giorgi-Cavaglieri Foundation, HUG Private Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The local and systemic symptoms that follow vaccination, collectively referred to as reactogenicity, are common, yet the mechanisms underlying individual variability remain poorly understood. Through longitudinal immune profiling of vaccinated individuals and mechanistic studies in mice, we identified key immunological determinants of reactogenicity induced by mRNA vaccines. Systemic adverse events were associated with stronger interferon and pro-inflammatory responses after the second dose of a COVID-19 mRNA vaccine, which were also correlated with the magnitude of the antigen-specific adaptive responses. This heightened inflammation occurred within 24 hours of vaccination, originated primarily from the injection site, and was characterized by enhanced recruitment and activation of myeloid cells, particularly monocytes. Two mechanisms contributed to this response: early interferon production by muscle T cells generated after the first dose and Fcγ receptor–dependent chemokine induction by vaccine antigen–specific antibodies. Consistently, serum antibody levels before vaccination correlated positively with reactogenicity. In addition to this local amplification mechanism, variability in reactogenicity was influenced by the baseline immune state, given that individuals with a preexisting interferon-stimulated gene signature in monocytes, detectable at both transcriptomic and epigenetic levels, were more prone to systemic symptoms. Together, our findings revealed molecular and cellular mechanisms driving vaccine reactogenicity, providing a framework for the design of less reactogenic vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MonocytesInterferonsSignal TransductionImmunity, InnatemRNA VaccinesCOVID-19 VaccinesAnimalsHumansMiceFemaleVaccinationMice, Inbred C57BLMale

Substanzen

InterferonsmRNA VaccinesCOVID-19 Vaccines

Autor:innen und Institutionen

  • Centre for Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Biomedical Data Science Facility, Faculty of Medicine, University of Geneva, Geneva Switzerland.
  • Department of Biomedicine, Division of Experimental Virology, University of Basel, Basel, Switzerland.
  • Department of Pathology and Immunology, Geneva Centre for Inflammation Research, University of Geneva and Division of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.
  • Translational Immunology Unit, Institut Pasteur, Université Paris Cite, Paris, France.
  • Center for Vaccinology, University Hospitals Geneva, Geneva, Switzerland.

ORCID-Profile: Natacha Madelon, Gustavo A Ruiz Buendía, Paula Torres Rodriguez, Matias Ciancaglini, Emma Arsac, Nicolas Fonta, Rachel Goldstein, Nelli Heikkila, Jamie Sugrue, Darragh Duffy, Doron Merkler, Daniel D Pinschewer, Christiane S Eberhardt, Raphael Gottardo, Cathal Harmon, Anthony DiPiazza, Arnaud M Didierlaurent

Förderung

  • Moderna
  • Giorgi-Cavaglieri Foundation
  • HUG Private Foundation

Zitieren

APA

Madelon, N., Ruiz Buendía, G. A., Torres Rodriguez, P., Donati, Y. R., Fontannaz, P., Ciancaglini, M., Adouan, W., Arsac, E., Fonta, N., Goldstein, R., Heikkila, N., Page, N., Sugrue, J., Duffy, D., Merkler, D., Pinschewer, D. D., Eberhardt, C. S., Gottardo, R., Harmon, C., …, & Didierlaurent, A. M. (2026). Baseline interferon signaling in monocytes and antibody-mediated innate activation are associated with reactogenicity to mRNA vaccines. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aee4776

Vancouver

Madelon N, Ruiz Buendía GA, Torres Rodriguez P, Donati YR, Fontannaz P, Ciancaglini M, et al. Baseline interferon signaling in monocytes and antibody-mediated innate activation are associated with reactogenicity to mRNA vaccines. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aee4776

BibTeX
@article{Madelon2026,
  author = {Madelon, Natacha and Ruiz Buendía, Gustavo A and Torres Rodriguez, Paula and Donati, Yves R and Fontannaz, Paola and Ciancaglini, Matias and Adouan, Wafae and Arsac, Emma and Fonta, Nicolas and Goldstein, Rachel and Heikkila, Nelli and Page, Nicolas and Sugrue, Jamie and Duffy, Darragh and Merkler, Doron and Pinschewer, Daniel D and Eberhardt, Christiane S and Gottardo, Raphael and Harmon, Cathal and DiPiazza, Anthony and Didierlaurent, Arnaud M},
  title = {Baseline interferon signaling in monocytes and antibody-mediated innate activation are associated with reactogenicity to mRNA vaccines},
  journal = {Science Translational Medicine},
  year = {2026},
  doi = {10.1126/scitranslmed.aee4776}
}
Kostenlos starten →